AI assistant
Sending…
Terns Pharmaceuticals, Inc. — Director's Dealing 2023
Dec 5, 2023
32559_dirs_2023-12-04_624fba6e-568b-4be5-94cf-11f61dfda4b7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Terns Pharmaceuticals, Inc. (TERN)
CIK: 0001831363
Period of Report: 2023-11-30
Reporting Person: Yoon Seokho Bryan (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-11-30 | Common Stock | P | 743.00 | $3.78 | Acquired | 18399.00 | Direct |
Footnotes
F1: Includes the purchase of 743 shares under the Terns Employee Stock Purchase Plan on November 30, 2023.